Showing results (3361-3370 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|March 29, 2011
External quality assessment for KRAS testing is needed: setup of a European program and report of the first joined regional quality assessment roundsEllen Bellon, Marjolijn J L Ligtenberg, Sabine Tejpar, et al.
The Oncologist|December 15, 2010
Treatment of unresectable and metastatic cutaneous squamous cell carcinomaLee D Cranmer, Candace Engelhardt, Sherif S Morgan
The Oncologist|December 15, 2010
Breast cancer and pregnancy: current concepts in diagnosis and treatmentJennifer K Litton, Richard L Theriault
The Oncologist|December 15, 2010
Phase I study of pazopanib in combination with weekly paclitaxel in patients with advanced solid tumorsAntoinette R Tan, Afshin Dowlati, Suzanne F Jones, et al.
The Oncologist|January 8, 2011
Increasing incidence of brain metastasis in patients with advanced hepatocellular carcinoma in the era of antiangiogenic targeted therapyYu-Yun Shao, Li-Chun Lu, Ann-Lii Cheng, et al.
The Oncologist|January 8, 2011
Early diagnosis of medullary thyroid carcinoma: is systematic calcitonin screening appropriate in patients with nodular thyroid disease?Giuseppe Costante, Sebastiano Filetti
The Oncologist|January 8, 2011
In the end what matters most? A review of clinical endpoints in advanced breast cancerSunil Verma, Deanna McLeod, Gerald Batist, et al.
The Oncologist|January 8, 2011
Quality of life implications of bisphosphonate-associated osteonecrosis of the jawRebecca Anne Miksad, Kuan-Chi Lai, Thomas Benton Dodson, et al.
The Oncologist|January 8, 2011
Systematic review of medical treatment in melanoma: current status and future prospectsClaus Garbe, Thomas K Eigentler, Ulrich Keilholz, et al.
The Oncologist|January 8, 2011
Visceral fat area as a new independent predictive factor of survival in patients with metastatic renal cell carcinoma treated with antiangiogenic agentsSylvain Ladoire, Franck Bonnetain, Mélanie Gauthier, et al.
Pageof 571